SRC
CVS icon

Shufro Rose & Co’s CVS Health CVS Stock Holding History

Shufro Rose & Co’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-1,000
Closed -$75K – 304
2021
Q1 		$75K Buy
+1,000
New +$72.8K 0.01% 294

Other funds holding CVS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Shufro Rose & Co's CVS Position: Q2 2026 in Review

Shufro Rose & Co opened a new position in CVS Health (CVS) in Q2 2026: 1,950 shares worth $202K. The stake represents 0.01% of the portfolio and ranks #292 among its holdings. This is a return to the name: Shufro Rose & Co previously reported a position in CVS as recently as Q3 2025.

Shufro Rose & Co first reported a position in CVS in Q2 2013 and has held it in 51 quarters since. The position peaked at $1.58M in Q4 2021. 2,069 funds tracked by Wall St. Rank hold CVS as of Q2 2026.

  • Shufro Rose & Co held 1,950 shares of CVS Health worth $202K as of Q2 2026.
  • CVS Health was a new Shufro Rose & Co position in Q2 2026.
  • CVS Health made up 0.01% of Shufro Rose & Co's portfolio in Q2 2026, its #292 holding.
  • Shufro Rose & Co first reported a position in CVS Health in Q2 2013 and has held it in 51 quarters since.
  • Shufro Rose & Co's CVS Health position peaked at $1.58M in Q4 2021.
  • 2,069 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.

Based on Shufro Rose & Co's 13F filing for Q2 2026, filed 12 Aug 2026.